In Fig 2, we have also demonstrated clear matriptase activation in standard growth conditions in two HER2-amplified breast cancer lines and here, we set out to determine the effect of matriptase-directed NAC treatment on this breast cancer subtype. This evidence concerns the gene ERBB2 and breast carcinoma.